Comprehensive molecular characterization of clear cell renal cell carcinoma | Nature
Frontiers | The Identification of Immunological Biomarkers in Kidney Cancers
How are biomarkers used to treat cancer? | MD Anderson Cancer Center
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine
Frontiers | LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma | Nature Reviews Urology
Diseases | Free Full-Text | Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review
Renal cancer biomarkers: the promise of personalized care | BMC Medicine | Full Text
Renal cancer biomarkers: the promise of personalized care | BMC Medicine | Full Text
The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions - ScienceDirect
Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition - ScienceDirect
Frontiers | Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect
Biomarkers in renal cell carcinoma: Are we there yet? - ScienceDirect
Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer - ScienceDirect
The immunology of renal cell carcinoma | Nature Reviews Nephrology
Frontiers | Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
Cabozantinib Slows Progression of Rare Kidney Cancer - NCI
Exosomes as a Multicomponent Biomarker Platform in Cancer: Trends in Cancer
Frontiers | The Identification of Immunological Biomarkers in Kidney Cancers
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population | Nature Communications
Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma | Nature Reviews Clinical Oncology
Potential biomarkers for kidney cancer - Action Kidney Cancer
Systemic Therapy for Metastatic Renal-Cell Carcinoma | NEJM
Molecular Imaging of Renal Cell Carcinoma in Precision Medicine | Molecular Pharmaceutics
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Biomarker discovery for renal cancer stem cells - Corrò - 2018 - The Journal of Pathology: Clinical Research - Wiley Online Library
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Renal cell carcinoma: the search for a reliable biomarker - Farber - Translational Cancer Research
